Association between Ki 67 expression and clinicopathological features in prognosis of breast cancer A retrospective cohort study
Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Background
Breast cancer is the most common diagnosed female cancer. Breast cancer is also the leading cause of cancer death in females accounting for 13.7% of female cancer‑related mortality globally. Variable known prognostic factors such as histological tumor type, tumor size, nodal status, grade, age, and estrogen receptor (ER) status and the proliferation marker – Ki‑67 influence the type of treatment decision. The purpose of this present study is to investigate the association between Ki‑67 expression with several clinicopathological variables and patients’ outcome.
Materials and Methods
This is a retrospective cohort study from September 2008 to March 2017; 165 newly diagnosed breast cancer patients were enrolled in the study. Ki67 levels were measured using immunohistochemistry and compared with clinicopathological variables. The relation of Ki67 expression with disease‑free survival (DFS) and overall survival (OS) was also analyzed.
Results
The result of this study revealed that age, tumor size, menopausal status, and human epidermal growth factor receptor 2 (HER2) status had no effect on the patients’ outcome. Patients with ER‑positive, progesterone receptor (PR)‑positive, and HER2‑negative tumors expressed a higher rate of Ki‑67 (>10%) than patients with ER‑negative, PR‑negative, and HER2‑positive tumors, respectively. However, we found that Ki‑67 levels were not significantly increased statistically with ER, PR, and HER2 statuses. There was a statistically significant correlation between Ki‑67 expression and with higher stages of the disease. Multivariate analysis showed that Ki‑67 expression could not to be an independent prognostic factor for 5‑year OS and DFS. Furthermore, p53 status was only prognostic factor for 5‑year OS whereas higher stages of disease and p53 status were prognostic factors for 5‑year DFS.
Conclusion
Ki67 could not be an independent variable for prediction of breast cancer outcome.
Language:
English
Published:
Journal of Research in Medical Sciences, Volume:24 Issue: 4, Apr 2019
Page:
4
magiran.com/p1978891  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 990,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 50 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!